Development of Antibody Therapeutics: Engineering, Characterization, and Safety Assessment | Agenda Bookshop Skip to content
Please note that books with a 10-20 working days delivery time may not arrive before Christmas.
Please note that books with a 10-20 working days delivery time may not arrive before Christmas.
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Patrick Liu
B01=Phillip D. K. Lee
B01=Roy Jefferis
Category1=Non-Fiction
Category=MJCM
Category=PN
Category=PSBM
COP=United Kingdom
Delivery_Delivery within 10-20 working days
Language_English
PA=Available
Price_€100 and above
PS=Active
softlaunch

Development of Antibody Therapeutics: Engineering, Characterization, and Safety Assessment

English

Including case studies of FDA-approved drugs, this book covers the processes and technologies in every step of antibody therapeutics development - history and background, process development, preclinical toxicology, manufacture, and regulations. It addresses cutting-edge topics like cell line generation, fermentation, antibody purification, product characterization, and preclinical and clinical evaluation. Detailing all pharmaceutical aspects of antibody engineering and production, it serves as a user's manual reference for the industry. See more
Current price €127.29
Original price €133.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Patrick LiuB01=Phillip D. K. LeeB01=Roy JefferisCategory1=Non-FictionCategory=MJCMCategory=PNCategory=PSBMCOP=United KingdomDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=AvailablePrice_€100 and abovePS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Dimensions: 150 x 250mm
  • Publication Date: 04 Jul 2017
  • Publisher: John Wiley and Sons Ltd
  • Publication City/Country: United Kingdom
  • Language: English
  • ISBN13: 9780470232910

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept